1. Is Clozapine Worth Its Cost?

   • Frances R. Frankenburg

   Guest Editorial 06 December 2012 Pages: 311 - 314

2. Strategic Use of Pharmacoeconomic Research in Early Drug Development and Global Pricing

   • Kevan Clemens
   • Louis P. Garrison Jr
   • Frances Macdonald

   Leading Article 06 December 2012 Pages: 315 - 322

3. The Role of Insurance Claims Databases in Drug Therapy Outcomes Research

   • Nancy J. W. Lewis
   • John T. Patwell
   • Becky A. Briesacher

   Review Article 06 December 2012 Pages: 323 - 330

4. Economic Implications of Smoking Cessation Therapies

   • David R. Cohen
   • G. H. Fowler

   Review Article 06 December 2012 Pages: 331 - 344

5. The Episode-Free Day as a Composite Measure of Effectiveness

   • Mark J. Sculpher
   • Martin J. Buxton

   Original Research Article 06 December 2012 Pages: 345 - 352

6. The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

   • Margaret C. Reilly
   • Arthur S. Zbrozek
   • Ellen M. Dukes

   Original Research Article 06 December 2012 Pages: 353 - 365

7. Cyclosporin

   • James E. Frampton
   • Diana Faulds

   Drug Evaluation 06 December 2012 Pages: 366 - 395

8. Erratum to Test of an Instrument to Measure Function-Related Quality of Life in Patients with Ulcerative Colitis

   • Arthur Zbrozek
   • Robert Hoop
   • Mike McPherson

   Erratum 06 December 2012 Pages: 395 - 395

9. Roxithromycin vs Cefaclor

   • Tom Hughes
   • W. Guy Scott
   • Bruce Cooper

   Letter to the Editor 06 December 2012 Pages: 396 - 398